Cargando…
The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer
The estrogen (ER) or progesterone receptors (PR) is positively associated with better clinical outcomes in ovarian cancer. Whether metastasis or recurrence of ovarian cancer is correlated with this association has not been investigated. Data on 894 women with epithelial ovarian cancer were collected...
Autores principales: | Chen, Shouzhen, Dai, Xujing, Gao, Yifei, Shen, Fang, Ding, Jingxin, Chen, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717220/ https://www.ncbi.nlm.nih.gov/pubmed/29208958 http://dx.doi.org/10.1038/s41598-017-17265-6 |
Ejemplares similares
-
Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?
por: Shen, Fang, et al.
Publicado: (2016) -
Estrogen, Progesterone and Epithelial Ovarian Cancer
por: Ho, Shuk-Mei
Publicado: (2003) -
Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer
por: Li, Ning, et al.
Publicado: (2022) -
Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
por: Chan, Melissa, et al.
Publicado: (2015) -
Estrogen Receptor Mutations and Changes in Estrogen Receptor and Progesterone Receptor Protein Expression in Metastatic or Recurrent Breast Cancer
por: Umekita, Yoshihisa, et al.
Publicado: (1998)